Prevention of Contrast Reactions

Risk Stratification - Spotting Trouble Early

• Goal: Identify patients needing premedication or alternative imaging.
• Key Historical Factors:
  • Prior moderate/severe allergic-like reaction to contrast: Strongest predictor.
  • Significant allergies (e.g., multiple, severe drug allergies).
  • Asthma: Particularly if poorly controlled or requiring systemic steroids.
• Patient Co-morbidities:
  • Severe atopy (e.g., eczema, allergic rhinitis).
  • Cardiac disease (e.g., unstable angina, heart failure): ↑ risk of severe outcome if reaction occurs.
  • Beta-blocker use: May ↑ severity & complicate management.

⭐ A history of a prior allergic-like reaction to contrast media increases the risk of a subsequent reaction by approximately 5-fold.

Premedication Protocols - Shield Up Doc!

• Goal: ↓ risk of allergic-like reactions to contrast media (CM) in at-risk patients.

• Key At-Risk Groups:

  • Prior moderate/severe CM reaction.
  • Asthma, significant allergies (atopy).

• Standard Oral Regimens (Elective):

  • Corticosteroid:
    • Prednisolone: 50 mg PO at 13h, 7h, 1h pre-CM. (📌 "Rule of 13-7-1")
    • OR Methylprednisolone: 32 mg PO at 12h, 2h pre-CM.
  • Antihistamine (H1 blocker):
    • Diphenhydramine: 50 mg PO/IM/IV 1h pre-CM.
  • (Optional: H2 blocker e.g., Famotidine 20 mg IV or Cimetidine 300 mg PO 1h prior)

• Rapid/Emergency Regimens (IV preferred):

  • Corticosteroid (IV, administer at least 4-6h prior if possible, or immediately if urgent):
    • Hydrocortisone: 200 mg IV.
    • OR Methylprednisolone: 40 mg IV.
  • Antihistamine (H1 blocker):
    • Diphenhydramine: 50 mg IV/IM 1h pre-CM (or as soon as possible).

⭐ Premedication primarily reduces incidence/severity of mild-moderate allergic-like reactions. It does not reliably prevent severe anaphylaxis or non-allergic reactions (e.g., CIN).

Safer Contrast Practices - Smart Choices, Smooth Scans

• Thorough Patient Assessment:
  • Detailed history: Previous contrast reactions, allergies (esp. asthma), renal function (eGFR), cardiac status, current medications (metformin, beta-blockers, NSAIDs, IL-2).
  • Identify high-risk patients.
• Optimal Contrast Choice:
  • Prefer Low-Osmolar (LOCM) or Iso-Osmolar (IOCM) agents.

    ⭐ LOCM/IOCM are associated with a 4-5 fold ↓ risk of adverse reactions compared to HOCM.

  • Non-ionic agents are generally safer than ionic ones.
  • Use the smallest diagnostic dose.
  • Warm contrast to body temperature (reduces viscosity).
• Procedural Precautions:
  • Ensure adequate hydration (oral/IV) pre- and post-procedure.
  • Avoid unnecessary repeat contrast studies within 24-72 hours.
  • Temporarily discontinue metformin in patients with eGFR < 30 mL/min/1.73m² or acute kidney injury receiving intra-arterial contrast.

High-Yield Points - ⚡ Biggest Takeaways

• Identify high-risk patients: History of prior reaction, asthma, significant allergies.
• Premedication with corticosteroids (e.g., Prednisolone) and antihistamines is crucial for high-risk cases.
• Prefer Low-Osmolar (LOCM) or Iso-Osmolar (IOCM) contrast agents.
• Maintain adequate hydration (oral/IV) before and after contrast administration.
• Discontinue Metformin for 48 hours post-contrast if eGFR <30 mL/min/1.73m² or AKI.
• Ensure immediate availability of emergency kit: epinephrine, O₂, IV fluids_._